Utah Medical Products
UTMD
90 hedge funds and large institutions have $247M invested in Utah Medical Products in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 29 increasing their positions, 38 reducing their positions, and 10 closing their positions.
3.49% less ownership
Funds ownership: 74.52% → 71.03% (-3.5%)
6% less funds holding
Funds holding: 96 → 90 (-6)
17% less capital invested
Capital invested by funds: $299M → $247M (-$51.9M)
24% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 38
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$1.15M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$685K |
| 3 |
Nuveen
Charlotte,
North Carolina
|
+$627K |
| 4 |
ProShare Advisors
Bethesda,
Maryland
|
+$487K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$422K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$2.71M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$2.45M |
| 3 |
PC
Port Capital
Chicago,
Illinois
|
-$1.95M |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$1.89M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.86M |
UTMD Hedge Fund Activity: Q1 2020 in Review
90 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q1 2020, worth a combined $247M — down 17% from $299M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of UTMD and 6 opened new positions — a net loss of 4 holders — while 38 trimmed existing stakes and 29 added.
The largest buyer was JP Morgan Chase, adding an estimated $1.15M. The largest seller was THB Asset Management, cutting an estimated $2.71M.
- 90 institutional investors held Utah Medical Products (UTMD) as of Q1 2020, down from 96 in Q4 2019.
- Funds reported $247M of Utah Medical Products stock for Q1 2020, down 17% quarter-over-quarter.
- 6 funds opened new Utah Medical Products positions in Q1 2020 and 10 closed out, a net change of -4 holders.
- The largest Utah Medical Products buyer in Q1 2020 was JP Morgan Chase, an estimated $1.15M added.
- The largest Utah Medical Products seller in Q1 2020 was THB Asset Management, an estimated $2.71M sold.
Based on aggregated 13F filings for Q1 2020.